July 12, 2026

Reed Jobs would rather talk about curing cancer than his last name

When we last sat down with Jobs at TechCrunch Disrupt nearly three years ago, his firm Yosemite was brand new and biotech was still reeling from its post-pandemic crash. Now, the venture outfit has a team of 17; a cluster of blockbuster drugs are all losing patent protection in roughly the same window, creating all kinds of new opportunities; and AI has gone from a curiosity to, in Jobs’s words, a huge part of what Yosemite does. “I didn’t expect Yosemite to be moving this fast,” he said.

Others

Ultra-portable monitor from Espresso Displays goes 4K

October 9, 2023
When I reviewed the Espresso Display last year, I concluded that it would be a great addition to a mobile office setup for workers who needed additional screen real estate without taking up too much space (and weight) in the travel setup. Now, Sydney-based Espresso Displays has launched its follow-up, the Espresso 17 Pro, further […]

Buzzy social app Fizz sues rival Sidechat over unfair competition practices

October 9, 2023
Fizz, the buzzy anonymous social app that’s now being used across over 80 college campuses, has filed suit against rival Sidechat, alleging unfair competition and a range of abuses, including attempts at disrupting Fizz’s launches, spreading rumors about Fizz having hackers, trademark infringements, sending false spam reports to Instagram, and using false pretenses to acquire […]

Hacktivism erupts in response to Hamas-Israel war

October 9, 2023
Several groups of hacktivists have targeted Israeli websites with floods of malicious traffic following a surprise land, sea and air attack launched against Israel by militant group Hamas on Saturday, which prompted Israel to declare war and retaliate. Israeli newspaper The Jerusalem Post reported Monday that since Saturday morning its website was down “due to […]